4.6 Article

SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00187.2011

Keywords

adenosine 5 '-monophosphate; follicle-stimulating hormone; gonadotropin; GATA

Funding

  1. Agencia Nacional de Promocion Cientifica, Argentina [PICT-2008-0521]
  2. Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina [PIP-11220090100615]
  3. Institut National de la Sante et de la Recherche Medicale-CONICET

Ask authors/readers for more resources

Lasala C, Schteingart HF, Arouche N, Bedecarras P, Grinspon RP, Picard JY, Josso N, di Clemente N, Rey RA. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1. Am J Physiol Endocrinol Metab 301: E539-E547, 2011. First published June 21, 2011; doi:10.1152/ajpendo.00187.2011.-In Sertoli cells, anti-Mullerian hormone (AMH) expression is upregulated by FSH via cyclic AMP (cAMP), although no classical cAMP response elements exist in the AMH promoter. The response to cAMP involves NF-kappa B and AP2; however, targeted mutagenesis of their binding sites in the AMH promoter do not completely abolish the response. In this work we assessed whether SOX9, SF1, GATA4, and AP1 might represent alternative pathways involved in cAMP-mediated AMH upregulation, using real-time RTPCR (qPCR), targeted mutagenesis, luciferase assays, and immunocytochemistry in the Sertoli cell line SMAT1. We also explored the signaling cascades potentially involved. In qPCR experiments, Amh, Sox9, Sf1, and Gata4 mRNA levels increased after SMAT1 cells were incubated with cAMP. Blocking PKA abolished the effect of cAMP on Sox9, Sf1, and Gata4 expression, inhibiting PI3K/PKB impaired the effect on Sf1 and Gata4, and reducing MEK1/2 and p38 MAPK activities curtailed Gata4 increase. SOX9 and SF1 translocated to the nucleus after incubation with cAMP. Mutations of the SOX9 or SF1 sites, but not of GAT4 or AP1 sites, precluded the response of a 3,063-bp AMH promoter to cAMP. In conclusion, in the Sertoli cell line SMAT1 cAMP upregulates SOX9, SF1, and GATA4 expression and induces SOX9 and SF1 nuclear translocation mainly through PKA, although other kinases may also participate. SOX9 and SF1 binding to the AMH promoter is essential to increase the activity of the AMH promoter in response to cAMP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Developmental Biology

AMH and AMHR2 Involvement in Congenital Disorders of Sex Development

Franco G. Brunello, Rodolfo A. Rey

Summary: Anti-mullerian hormone (AMH) is crucial for male fetal genital development, with its deficiency potentially leading to abnormalities. Defects in the AMH pathway, resulting in Persistent Mullerian Duct Syndrome, cause a rare condition where patients have male external genitalia but also internal female reproductive organs.

SEXUAL DEVELOPMENT (2022)

Editorial Material Endocrinology & Metabolism

Genetics of reproductive endocrinology Preface

Rodolfo A. Rey

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Growth, puberty and testicular function in boys born small for gestational age with a nonspecific disorder of sex development

Lloyd J. W. Tack, Saskia van der Straaten, Stefan Riedl, Alexander Springer, Paul-Martin Holterhus, Nadine C. Hornig, Zofia Kolesinska, Marek Niedziela, Federico Baronio, Antonio Balsamo, Sabine E. Hannema, Anna Nordenstrom, Sukran Poyrazoglu, Fatma F. Darendeliler, Romina Grinspon, Rodolfo Rey, Fahad Aljuraibah, Jillian Bryce, Faisal Ahmed, Rieko Tadokoro-Cuccaro, Ieuan Hughes, Guilherme Guaragna-Filho, Andrea T. Maciel-Guerra, Gil Guerra-Junior, Martine Cools

Summary: The study found that almost one out of three SGA boys experience insufficient catch-up growth by the age of 2. Additionally, SGA boys had higher LH levels during minipuberty and lower testosterone levels in stimulation tests.

CLINICAL ENDOCRINOLOGY (2022)

Review Endocrinology & Metabolism

Up-to-Date Clinical and Biochemical Workup of the Child and the Adolescent with a Suspected Disorder of Sex Development

Romina P. Grinspon, Sebastian Castro, Rodolfo A. Rey

Summary: In this review, we present a practical and updated approach to clinical and hormonal laboratory workup for newborns, children, and adolescents with suspected DSD. We emphasize the importance of tailoring the diagnostic approach based on age and presentation.

HORMONE RESEARCH IN PAEDIATRICS (2023)

Article Biochemistry & Molecular Biology

The anti-Mullerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor

Richard L. Cate, Nathalie di Clemente, Chrystele Racine, Nigel P. Groome, R. Blake Pepinsky, Adrian Whitty

Summary: This study demonstrates that complexes of transforming growth factor-beta family growth/differentiation factors with their prodomains undergo prodomain displacement upon binding to their respective receptors. Bivalent binding of the complex to the receptor leads to rapid release of the prodomain, suggesting a general mechanism of receptor-mediated prodomain displacement.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Review Endocrinology & Metabolism

Recent advancement in the treatment of boys and adolescents with hypogonadism

Rodolfo A. Rey

Summary: Clinical manifestations and treatment needs of hypogonadism in males vary according to age. Early onset hypogonadism may result in disorders of sex development, while hypogonadism established later in fetal life presents with micropenis, cryptorchidism, and/or micro-orchidism. Diagnosis of hypogonadism becomes challenging after neonatal activation of the gonadal axis diminishes. Treatment usually focuses on micropenis and/or cryptorchidism in infancy and childhood, and on lack of pubertal development and relative short stature in teenagers.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2022)

Editorial Material Endocrinology & Metabolism

Next-Generation Sequencing as First-Line Diagnostic Test in Patients With Disorders of Sex Development?

Rodolfo A. Rey

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Pediatrics

Delayed Puberty Due to a WDR11 Truncation at Its N-Terminal Domain Leading to a Mild Form of Ciliopathy Presenting With Dissociated Central Hypogonadism: Case Report

Sebastian Castro, Franco G. Brunello, Gabriela Sanso, Paula Scaglia, Maria Esnaola Azcoiti, Agustin Izquierdo, Florencia Villegas, Ignacio Bergada, Maria Gabriela Ropelato, Marcelo A. Marti, Rodolfo A. Rey, Romina P. Grinspon

Summary: Pubertal delay in males can be caused by constitutional delay of growth and puberty or pathologic hypogonadism. Central (or hypogonadotropic) hypogonadism, resulting from a defective function of the GnRH/gonadotropin axis, is the main differential diagnosis after ruling out general illnesses and primary testicular failure. Ciliopathies arising from defects in non-motile cilia can cause developmental disorders affecting the sense organs and reproductive system.

FRONTIERS IN PEDIATRICS (2022)

Review Endocrinology & Metabolism

AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications

Nadia Y. Edelsztein, Clara Valeri, Maria M. Lovaisa, Helena F. Schteingart, Rodolfo A. Rey

Summary: Anti-Mullerian hormone (AMH) is a biomarker of immature Sertoli cells, which is regulated by specific transcription factors and plays a role in the regression of Mullerian ducts in males. AMH is highly expressed before puberty and then downregulated. FSH increases AMH output, while intratesticular levels of androgens and estrogens also regulate AMH secretion.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Biochemistry & Molecular Biology

Anti-Mullerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent

Nathalie di Clemente, Chrystele Racine, Rodolfo A. Rey

Summary: This article reviews the main findings on anti-Mullerian hormone (AMH) and its involvement in the pathogenesis of polycystic ovary syndrome (PCOS) and its male equivalent. AMH has important roles in ovarian reserve, follicular development, and the differentiation of the genital tract. It is also used to assess Sertoli cell function in children and has potential implications for male fertility.

BIOMEDICINES (2022)

Editorial Material Endocrinology & Metabolism

Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms

Lourdes Correa Brito, Rodolfo A. Rey

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Endocrinology & Metabolism

Assessment of testicular function in boys and adolescents

Jimena Lopez Dacal, Sebastian Castro, Sofia Suco, Lourdes Correa Brito, Romina P. Grinspon, Rodolfo A. Rey

Summary: This review addresses the approaches to evaluate the hypothalamic-pituitary-testicular axis in newborns, children, and adolescents, focusing on hormonal laboratory and genetic studies, clinical signs, and imaging studies.

CLINICAL ENDOCRINOLOGY (2023)

Article Health Care Sciences & Services

Identification of a Novel Variant in Myelin Regulatory Growth Factor by Next-Generation Sequencing Led to the Detection of a Clinically Inapparent Congenital Heart Defect in a Patient with a 46,XY Disorder of Sex Development

Lourdes Correa Brito, Romina P. Grinspon, Jimena Lopez Dacal, Paula Scaglia, Maria Esnaola Azcoiti, Agustin Izquierdo, Maria Gabriela Ropelato, Rodolfo A. Rey

Summary: This study reported a case of a patient with 46,XY disorders of sex development (DSDs) in whom a novel variant in MYRF gene was identified, leading to the detection of a clinically inapparent congenital heart defect.

JOURNAL OF PERSONALIZED MEDICINE (2023)

No Data Available